Searched query = "Idiopathic thrombocytopenic purpura", "Primary immune thrombocytopenia"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
|1||JPRN-JapicCTI-153003||01/9/2015||Drug use surveillance of Takecab for Supplement to Helicobacter pylori eradication||Drug use surveillance of Takecab tablets Supplement to Helicobacter pylori eradication||The following diseases in patients for whom H. pylori will be eradicated with triple therapy: Gastric ulcer, duodenal ulcer, gastric mucosa-associated lymphoid tissue (MALT) lymphoma, idiopathic thrombocytopenic purpura, stomach following endoscopic treatment of early gastric cancer, or H. pylori gastritis||Intervention name : Takecab tablets + amoxicillin + clarithromycin (first-line eradication) Takecab tablets + amoxicillin + metronidazole (second-line eradication)|
Dosage And administration of the intervention : For adults, the following three-drug regimen will be administered orally at the same time twice daily for 7 days: 20 mg dose of vonoprazan, 750 mg (potency) dose of amoxicillin hydrate, and 200 mg (potency) dose of clarithromycin. The dose of clarithromycin may be increased as clinically warranted. However, dosage should not exceed 400 mg (potency)/dose twice daily. If H. pylori eradication with a three-drug regimen comprising vonoprazan or proton pump inhibitor + amoxicillin hydrate + clarithromycin has been unsuccessful, as an alternative treatment, the following three drugs will be administered orally twice daily for 7 days to adults: 20 mg dose of vonoprazan, 750 mg (potency) dose of amoxicillin hydrate, and 250 mg dose of metronidazole. Participants will receive interventions as part of routine medical care.
Control intervention name : null
|TAKEDA PHARMACEUTICAL COMPANY LTD.||NULL||BOTH||500||NA||NULL|
|September 1, 2015||9/7/2017||Drug Use Surveillance of Takecab for Supplement to Helicobacter Pylori Eradication||Drug Use Surveillance of Takecab Tablets Supplement to Helicobacter Pylori Eradication||Gastric/Duodenal Ulcer, Gastric MALT Lymphoma, Idiopathic Thrombocytopenic Purpura, or H. Pylori Gastritis, and Other||Drug: Vonoprazan;Drug: Amoxicillin hydrate;Drug: Clarithromycin;Drug: Metronidazole||Takeda||NULL||Completed||N/A||N/A||All||560||Japan|
|March 2006||27/4/2007||Helicobacter Pylori Infection in Children With Chronic Idiopathic Thrombocytopenic Purpura||Helicobacter Pylori Infection in Children With Chronic Idiopathic Thrombocytopenic Purpura||Chronic Idiopathic Thrombocytopenic Purpura;Helicobacter Pylori Infection||Drug: lansoprazole, clarithromycin, amoxycillin||Mahidol University||Ramathibodi Hospital||Completed||2 Years||18 Years||Both||26||Phase 4||Thailand|